# Euclises Pharmaceuticals, Inc. — Form D/A

Euclises Pharmaceuticals, Inc. of ST. LOUIS, MO, a company, filed a Form D amendment with the SEC on 2016-12-01. The offering totals $2.7M, of which $1.2M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2016-12-01
- Form: D/A
- Accession: 0001550350-16-000003
- Industry: Pharmaceuticals
- Exemptions: 06c
- Total offering: $2.7M
- Amount sold: $1.2M
- Remaining: $1.5M
- Minimum investment: $1
- Investors: 5
- Date of first sale: 2015-11-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-248588

## Issuer

- Name: Euclises Pharmaceuticals, Inc.
- CIK: 0001550350
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 4320 FOREST PARK AVENUE, SUITE 303, ST. LOUIS, MO, 63108
- Phone: (314) 604-2850

## Officers, directors & promoters (15)

| Name | Role | Location |
| --- | --- | --- |
| Robert A Beardsley | Director | Grand Rapids, MI |
| Charles A Bolten | Director | St. Louis, MO |
| Robert J Calcaterra | Director | St. Louis, MO |
| Rajesh J Devraj | Director | St. Louis, MO |
| Rick J Ryan | Director | St. Louis, MO |
| BOBBY W SANDAGE, JR. | Director | ST. LOUIS, MO |
| John J Talley | Director | St. Louis, MO |
| BOBBY W SANDAGE, JR. | Executive Officer | ST. LOUIS, MO |
| Eduardo J Martinez | Director | Cambridge, MA |
| Rajesh J Devraj | Executive Officer | St. Louis, MO |
| Robert W Karr | Director | SAINT LOUIS, MO |
| Robert W Karr | Executive Officer | SAINT LOUIS, MO |
| Rick A Ryan | Director | St. Louis, MO |
| Randy H Weiss | Director | St. Louis, MO |
| Randy H Weiss | Executive Officer | St. Louis, MO |

## Other filings by this issuer (4)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2015-10-01](https://search.stillhousedata.com/formd/0001550350-15-000002) | D | $663K | — |
| [2015-10-01](https://search.stillhousedata.com/formd/0001550350-15-000001) | D/A | $1.9M | $1.9M |
| [2014-01-13](https://search.stillhousedata.com/formd/0001550350-14-000001) | D | $1.4M | $300K |
| [2012-05-17](https://search.stillhousedata.com/formd/0001550350-12-000001) | D | $400K | $175K |

## More

- [CIK 1550350 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1550350&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001550350-16-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.